First Patient Enrollment in AGILITY Study Begins Investigations of Safety and Effectiveness of BD Vascular Covered Stent for Treatment of PAD...
A game-changer in healthcare technology with unparalleled performance...
This Marks the Company's Eleventh FDA-Cleared Indication-for-Use...
Award gives priority US regulatory review to Company’s ARC-BCI™ System...
A Ground breaking Advancement in Surgical Technology...
Joerns Healthcare and MasVida Health Forge Strategic Partnership...
Validic Integrates Smart Meter Cellular-Enabled Devices into its Comprehensive Care Platform...
MicroPort® MedBot™ JV’s R-ONE®, the World's First Dual-Finger Grasp Mimic Vascular Intervention Robot, Receives Approval in China...
Tucson Medical Center Implants First Patient with Novel Investigational Device...
In a landmark development for medical device innovation and accessibility in the Gulf region, Zylox-Tonbridge (2190.HK) has successfully received marketing approval from the Ministry of Health and Prevention in the United Arab Emirates for a suite of its cutting-edge products. This approval encompasses the ZENFluxion™ Drug-coated PTA Balloon Catheter, ZENFlow™ HP PTA Balloon Catheter, ZENFlow™ PTA Balloon Catheter, ZENFlex™ Peripheral Stent System, and ZENFLEX Pro™ Peripheral Drug-eluting Stent ...
